Cargando…
BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling
For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and paucity of knowledge about the mechanism of chemoresistance are major stumbling blocks in the management of this disease. Here, we provide compelling evidence that BMI1 polycomb group protein and a stem...
Autores principales: | Siddique, Hifzur Rahman, Parray, Aijaz, Tarapore, Rohinton S., Wang, Lei, Mukhtar, Hasan, Karnes, R. Jeffery, Deng, Yibin, Konety, Badrinath R., Saleem, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645992/ https://www.ncbi.nlm.nih.gov/pubmed/23671559 http://dx.doi.org/10.1371/journal.pone.0060664 |
Ejemplares similares
-
BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
por: Siddique, Hifzur Rahman, et al.
Publicado: (2013) -
Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
por: Siddique, Hifzur Rahman, et al.
Publicado: (2013) -
Castration-resistant prostate cancer: potential targets and therapies
por: Parray, Aijaz, et al.
Publicado: (2012) -
Differential Effects of Genistein on Prostate Cancer Cells Depend on Mutational Status of the Androgen Receptor
por: Mahmoud, Abeer M., et al.
Publicado: (2013) -
The Polycomb protein, Bmi1, regulates insulin sensitivity
por: Cannon, Corey E., et al.
Publicado: (2014)